BSX Financial Facts

Gain on divestiture: 2M
Contingent consideration expense: 22M
See Full Income Statement

Deferred income taxes: 288M
Commitments and contingencies: 0
See Full Balance Sheet

Boston Scientific (BSX) Earnings

  |   Expand Research on BSX
Next EPS Date N/A EPS Growth Rate +16.7% *Last Qtr.
Average EPS % Beat Rate +77.1% Revenue Growth Rate +1.1% *Last Qtr.
Average % Move 1-Wk after EPS +3.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
12/31/13 Q413 $0.21$0.13 +$0.08$1.84B$1.83B N/A +5.2% Details
10/24/13 Q313 $0.17$0.09 +$0.08$1.74B$1.73B = +11.4% Details
7/25/13 Q213 $0.18$0.10 +$0.08$1.81B$1.78B = +42.5% Details
4/25/13 Q113 $0.16$0.09 +$0.07$1.76B$1.79B = +86% Details
1/29/13 Q412 $0.18$0.11 +$0.07$1.82B$1.76B = +99.6% Details
10/18/12 Q312 $0.16$0.11 +$0.05$1.74B$1.76B = +143.6% Details
7/26/12 Q212 $0.17$0.10 +$0.07$1.83B$1.89B = +156.8% Details
4/19/12 Q112 $0.15$0.08 +$0.07$1.87B$1.86B = +147.1% Details